Masahiro Irifune

Prof. Dr. Masahiro Irifune

Hiroshima University
orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2003 in Anesthesia & Analgesia
Verified
Journal Article
Closed access
MIMasahiro Irifune
Masahiro Irifune
TTTohru Takarada
Tohru Takarada
YSYoshitaka Shimizu
Yoshitaka Shimizu
CEChie Endo
Chie Endo
SKSohtaro Katayama
Sohtaro Katayama
MKMichio Kawahara
Michio Kawahara
All drugs were administered intraperitoneally. General anesthetic potencies were evaluated using a righting reflex assay. The GABAA receptor agonist muscimol potentiated propofol (140 mg/kg; 50% effective dose for loss of righting reflex) induced anesthesia. Similarly, the benzodiazepine receptor agonist diazepam and the NMDA receptor antagonist MK-801 augmented propofol anesthesia, but the non-NMDA receptor antagonist CNQX did not. In contrast, the GABAA receptor antagonist bicuculline antagonized propofol (200 mg/kg; 95% effective dose for loss of righting reflex) induced anesthesia. However, neither the benzodiazepine receptor antagonist flumazenil, the GABA synthesis inhibitor l-allylglycine, nor the NMDA receptor agonist NMDA reversed propofol anesthesia. Conversely, the non-NMDA receptor agonist kainate enhanced propofol anesthesia. These results suggest that propofol-induced anesthesia is mediated, at least in part, by both GABAA and excitatory amino acid receptors....

1 July 2000 in Anesthesia & Analgesia
Verified
Journal Article
Closed access
MIMasahiro Irifune
Masahiro Irifune
TSTomoaki Dds Sato
Tomoaki Dds Sato
YKYoshiko Kamata
Yoshiko Kamata
TNTakashige Nishikawa
Takashige Nishikawa
TDToshihiro Dohi
Toshihiro Dohi
MKMichio Kawahara
Michio Kawahara
We examined the potentiation by ketamine of the γ-aminobutyric acidA (GABAA) receptor function using convulsive and anesthetic behavioral models in adult male ddY mice. General anesthetic potencies were evaluated by a rating scale, which provided the data for anesthetic scores, loss of righting reflex, duration, and recovery time. All drugs were administered intraperitoneally. Small subanesthetic doses of ketamine did inhibit tonic seizures induced by a large dose of the GABAA receptor antagonist bicuculline (8 mg/kg). The 50% effective dose value was 15 (95% confidence limits 10–22) mg/kg. Even large anesthetic doses (100–150 mg/kg) did not suppress clonic seizures in 50% of the animals. The GABAA receptor agonist, muscimol (0.32–1.12 mg/kg), potentiated ketamine-induced anesthesia in a dose-dependent fashion (P < 0.05). Similarly, the benzodiazepine receptor agonist, diazepam (1–3 mg/kg), augmented ketamine anesthesia in a dose-dependent manner (P < 0.05). Bicuculline (2–5 mg/kg) dose-dependently antagonized ketamine-induced anesthesia (P < 0.05). Neither the benzodiazepine receptor antagonist, flumazenil (2–20 mg/kg), nor the GABA synthesis inhibitor, l-allylglycine (200 mg/kg), affected the anesthetic action of ketamine. These results suggest that ketamine has GABAA receptor agonistic properties and that ketamine-induced anesthesia is mediated, at least in part, by GABAA receptors. Implications We examined the potentiation by ketamine of the γ-aminobutyric acidA receptor function using convulsive and anesthetic behavioral models in mice. Subanesthetic doses of ketamine-inhibited tonic convulsions induced by the γ-aminobutyric acidA receptor antagonist bicuculline. The γ-aminobutyric acidA receptor agonist, muscimol, potentiated ketamine-induced anesthesia. Bicuculline antagonized ketamine anesthesia, but the benzodiazepine receptor antagonist, flumazenil, and the γ-aminobutyric acid synthesis inhibitor, l-allyglycine, did not. The effects of ketamine on the γ-aminobutyric acidA receptors appear to correlate with its anesthetic actions.

1 June 2007 in Anesthesia & Analgesia
Verified
Journal Article
Closed access
MIMasahiro Irifune
Masahiro Irifune
NKNobuhito Kikuchi
Nobuhito Kikuchi
TSTakuya Saida
Takuya Saida
TTTohru Takarada
Tohru Takarada
YSYoshitaka Shimizu
Yoshitaka Shimizu
MKMichio Kawahara
Michio Kawahara
The general anesthetic state comprises behavioral and perceptual components, including amnesia, unconsciousness, analgesia, and immobility. In vitro, glutamatergic excitatory neurons are important targets for anesthetic action at the cellular and microcircuits levels. Riluzole (2-amino-6-[trifluoromethoxy]benzothiazole) is a neuroprotective drug that inhibits glutamate release from nerve terminals in the central nervous system. Here, we examined in vivo the ability of riluzole to produce components of the general anesthetic state through a selective blockade of glutamatergic neurotransmission. Riluzole was administered intraperitoneally in adult male ddY mice. To assess the general anesthetic components, three end-points were used: 1) loss of righting reflex (LORR; as a measure of unconsciousness), 2) loss of movement in response to noxious stimulation (as a measure of immobility), and 3) loss of nociceptive response (as a measure of analgesia). The intraperitoneal administration of riluzole induced LORR in a dose-dependent fashion with a 50% effective dose value of 27.4 (23.3-32.2; 95% confidence limits) mg/kg. The behavioral and microdialysis studies revealed that time-course changes in impairment and LORR induced by riluzole corresponded with decreased glutamate levels in the mouse brain. This suggests that riluzole-induced LORR (unconsciousness) could result, at least in part, from its ability to decrease brain glutamate concentrations. Riluzole dose-dependently produced not only LORR, but also loss of movement in response to painful stimulation (immobility), and loss of nociceptive response (analgesia) with 50% effective dose values of 43.0 (37.1-49.9), and 10.0 (7.4-13.5) mg/kg, respectively. These three dose-response curves were parallel, suggesting that the behavioral effects of riluzole may be mediated through a common site of action. These findings suggest that riluzole-induced LORR, immobility, and antinociception appear to be associated with its ability to inhibit glutamatergic neurotransmission in the central nervous system.

1 December 2007 in Canadian Journal of Anesthesia/Journal canadien d'anesthésie
Verified
Journal Article
Closed access
PDF file
MIMasahiro Irifune
Masahiro Irifune
SKSohtaro Katayama
Sohtaro Katayama
TTTohru Takarada
Tohru Takarada
YSYoshitaka Shimizu
Yoshitaka Shimizu
CEChie Endo
Chie Endo
MKMichio Kawahara
Michio Kawahara

11 January 2022 in Clinical and Experimental Dental Research
Verified
Journal Article
Open access
PDF file
KSKazuma Suzuki
Kazuma Suzuki
YSYoshitaka Shimizu
Yoshitaka Shimizu
SOShinichiro Ohshimo
Shinichiro Ohshimo
KOKana Oue
Kana Oue
NSNoboru Saeki
Noboru Saeki
NSNobuaki Shime
Nobuaki Shime
Objectives: Daily assessments of swallowing function and interventions such as rehabilitation and dietary adjustments are necessary to improve dysphagia. Cervical auscultation is convenient for health care providers for assessing swallowing ability. Although this method allows for swallowing sound evaluations, sensory evaluations with this method are difficult. Thus, we aimed to assess swallowing sound by the combined use of an electronic stethoscope and an artificial intelligence (AI) system that incorporates sound recognition.Material and Methods: Herein, 20 fifth‐year dentistry student volunteers were included; each participant was drank 10 ml and then 20 ml of water in different positions (sitting and supine). We developed an algorithm for indexing bolus inflow sounds using AI, which compared the swallowing sounds and created a new index.Results: The new index value used for swallowing sound was significantly higher in men than in women and in the sitting position than in the supine position. A software for acoustic analysis confirmed that the swallowing index was significantly higher in men than in women as well as in the sitting position than in the supine position. These results were similar to those obtained using the new index. However, the new index substantially differed between sexes in terms of posture compared with effective sound pressure.Conclusions: We developed a new algorithm for indexing swallowing sounds using a stethoscope and an AI system, which could identify swallowing sounds. For future research and development, evaluations of patients with dysphagia are necessary to determine the efficacy of the new index for bedside screening of swallowing conditions.

2 April 2021 in Molecules
Verified
Journal Article
Open access
PDF file
TKTakahiro kochi
Takahiro kochi
YNYoki Nakamura
Yoki Nakamura
SMSimeng Ma
Simeng Ma
KHKazue Hisaoka-Nakashima
Kazue Hisaoka-Nakashima
DWDengli Wang
Dengli Wang
NMNorimitsu Morioka
Norimitsu Morioka
Persistent pain following orofacial surgery is not uncommon. High mobility group box 1 (HMGB1), an alarmin, is released by peripheral immune cells following nerve injury and could be related to pain associated with trigeminal nerve injury. Distal infraorbital nerve chronic constriction injury (dIoN-CCI) evokes pain-related behaviors including increased facial grooming and hyper-responsiveness to acetone (cutaneous cooling) after dIoN-CCI surgery in mice. In addition, dIoN-CCI mice developed conditioned place preference to mirogabalin, suggesting increased neuropathic pain-related aversion. Treatment of the infraorbital nerve with neutralizing antibody HMGB1 (anti-HMGB1 nAb) before dIoN-CCI prevented both facial grooming and hyper-responsiveness to cooling. Pretreatment with anti-HMGB1 nAb also blocked immune cell activation associated with trigeminal nerve injury including the accumulation of macrophage around the injured IoN and increased microglia activation in the ipsilateral spinal trigeminal nucleus caudalis. The current findings demonstrated that blocking of HMGB1 prior to nerve injury prevents the onset of pain-related behaviors, possibly through blocking the activation of immune cells associated with the nerve injury, both within the CNS and on peripheral nerves. The current findings further suggest that blocking HMGB1 before tissue injury could be a novel strategy to prevent the induction of chronic pain following orofacial surgeries.